KraneShares Emerging Markets Healthcare Index ETF
KMED
KMED was delisted on the 18th of October, 2023.
2 hedge funds and large institutions have $638K invested in KraneShares Emerging Markets Healthcare Index ETF in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
55% more capital invested
Capital invested by funds: $411K → $638K (+$227K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$251K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.31K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
KMED Hedge Fund Activity: Q2 2023 in Review
2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q2 2023, worth a combined $638K — up 55% from $411K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KMED and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $251K. The largest seller was UBS Group, cutting an estimated $8.31K.
- 2 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q2 2023, down from 3 in Q1 2023.
- Funds reported $638K of KraneShares Emerging Markets Healthcare Index ETF stock for Q2 2023, up 55% quarter-over-quarter.
- 0 funds opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q2 2023 was Jane Street, an estimated $251K added.
- The largest KraneShares Emerging Markets Healthcare Index ETF seller in Q2 2023 was UBS Group, an estimated $8.31K sold.
Based on aggregated 13F filings for Q2 2023.